Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Biohaven Announces Positive Results of Acute Migraine Treatment From Two Trials
The pharmaceutical company announced that rimegepant, for the acute treatment of migraines, demonstrated superiority to placebo and met the co-primary endpoints of pain freedom and freedom from the most bothersome symptom in 2 pivotal phase 3 trials.
National Youth HIV/AIDS Awareness Day: Highlighting the Impact of Disease on the Age Group
As April 10 marks National Youth HIV & AIDS Awareness Day, CDC and other organizations are highlighting the impact of HIV/AIDS on individuals aged 13 to 24, as they accounted for nearly one-fourth of all new HIV diagnoses in the United States in 2015.
TCGA Completes Comprehensive Genomic Analysis of 33 Cancer Types
After a decade of analyzing over 11,000 tumors from 33 types of cancer, the collaboration between the National Cancer Institute and National Human Genome Research Institute has launched the Pan-Cancer Atlas, providing a comprehensive understanding of 3 focus areas: cell-of-origin patterns, oncogenic processes, and signaling pathways.
Pembrolizumab as First-Line Treatment Significantly Improves Overall Survival in NSCLC Trial
Pembrolizumab (Keytruda) monotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer (NSCLC) met its primary endpoint of overall survival in the Phase 3 KEYNOTE-042 trial when compared with standard of care platinum-based chemotherapy.
Pembrolizumab Combination Fails to Meet Primary Endpoint in Melanoma Study
The pivotal phase 3 ECHO-301/KEYNOTE-252 study evaluating Incyte’s epacadostat in combination with Merck’s pembrolizumab (Keytruda) in patients with unresectable or metastatic melanoma will be stopped after failing to meet its primary endpoint, according to a joint press release.
Locations, Types, and Characteristics of Data Breaches in Hospitals
As healthcare data breaches continue to rise, a team of researchers identified locations in hospitals where data are breached, the types of breaches that occur most often at hospitals, and hospital characteristics that may predict large data breaches that affect 500 or more patients.
Home-Delivered Meals Keep Medicare, Medicaid Population Out of ED, Lower Costs
With food insecurity attributing to $77 billion in excess healthcare expenditures annually, support services such as meal programs have been implemented. A study in Health Affairs found that meal delivery programs reduce the use of costly healthcare services, such as emergency department (ED) visits, and help cut costs for dually eligible Medicare and Medicaid beneficiaries.
Nongroup Enrollees Plan to Continue Purchasing Coverage Despite Repeal of Individual Mandate
Nine in 10 people with non-group health insurance will continue buying coverage despite the repeal of the individual mandate and express worry over future availability and price of health coverage, according to a health tracking poll from Kaiser Family Foundation. The poll also found that for the uninsured, the main reason for not purchasing coverage is that it is too expensive.
Insight Into ASCO's Evaluation of Clinical Pathway Vendors
Following the American Society of Clinical Oncology's (ASCO's) evaluation of leading oncology clinical pathway vendors nationwide, an article in Journal of Clinical Pathways provided insight into the evaluation from 2 of the report's co-authors.
HIV Incidence, Prevalence Remain Highest in Men Who Have Sex With Men
While years of efforts to combat the HIV epidemic have resulted in major successes, progress in reducing infection among men who have sex with men has lagged as they remain the most affected population, according to a study in Annals of Internal Medicine.
Hospital Acquisition of Independent Physician Practices Continues to Increase
Between July 2015 and July 2016, hospitals acquired 5000 independent physician practices, and the number of physicians employed by hospitals grew by 14,000, according to a report from Avalere Health and the Physicians Advocacy Institute.
FDA Approves Brentuximab Vedotin for Frontline Treatment of Classical Hodgkin Lymphoma
The FDA has approved brentuximab vedotin (Adcentris) in combination with chemotherapy for adults with previously untreated state 3 or 4 classical Hodgkin lymphoma based on results of the ECHELON-1 study.
Maryland All-Payer Hospital Model Reduces Costs, Lowers Readmissions
In 2014, Maryland and CMS entered a 5-year agreement employing the All-Payer Hospital Model in the state to cut costs while improving quality. According to the year 3 performance data, Maryland has met or is on track to meet all model requirements, saving hundreds of millions of dollars as it lowers hospital readmissions and steers the state away from a volume-based system.
CMS Finalizes Coverage for Next-Generation Sequencing Tests
CMS has finalized a National Coverage Determination (NCD) that covers diagnostic laboratory tests that use Next Generation Sequencing (NGS) for patients with advanced cancer, according to a press release. The finalization comes a few months after the FDA granted approval to FoundationOne CDx, the first-of-a-kind comprehensive companion diagnostic test for solid tumors.
Despite Increasing Rates of PrEP Usage, Disparities Remain Among African Americans, Latinos
While rates of pre-exposure prophylaxis (PrEP) usage among Americans have significantly increased year over year since PrEP gained approval for HIV prevention in 2012, significant gaps exist among African Americans and Latinos, according to analyses from AIDSVu and the CDC.
PCORI Reports Latest Findings From 5 of Their Funded Studies
The Patient-Centered Outcomes Institute shared results of 5 recent publications summarizing results from their awardees. The studies included research on a decision aid for patients with heart failure, 2 different approaches to treating mental illness, and addressing chronic pain.
Pembrolizumab Granted Priority Review for Treatment of Cervical Cancer
The FDA has accepted a new supplemental Biologics License Application and granted Priority Review for Merck's pembrolizumab (Keytruda) for the treatment of advanced cervical cancer, marking the first filing acceptance for an anti–PD-1 therapy in cervical cancer.
Precision Health AI Launches Platform to Deliver Data-Driven Insights in Oncology
Precision Health AI has launched Eureka Health, a platform that leverages electronic medical record data to provide artificial intelligence through more than 60 pretrained and learning-enhanced modules designed specifically for oncology.
The Shift From Episodic to Continuous Care: Wearable Technology and Telemedicine in Cardiology
Discussing the integration of data from wearable technology into the electronic health record and utilizing telemedicine as a way to promote greater collaboration between the patient and their physician and health system with Jagmeet P. Singh, MD, PhD, FACC, deputy editor of JACC: Clinical Electrophysiology, and Fred Bove, MD, MACC, editor-in-chief of Cardiology magazine.